Stage 5 chronic kidney disease (on maintenance hemodialysis) with kidney-related anemia
Conditions
Interventions
Suboptimal Anemia Control Group:None
Anemia Target-Achievement Group:None
Sponsors
Mindong Hospital of Ningde City
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age 18 or older; 2. Had been on maintenance hemodialysis before the observation period (before December 1, 2025) for at least 3 months; 3. During the observation period (December 2025 - May 2026), had prescriptions for Roxadustat (Auryxia/BeiRuisheng, etc.) at our outpatient clinic; 4. During the observation period, had at least 2 outpatient Roxadustat prescriptions with a total usage of at least 2 months.
Exclusion criteria
Exclusion criteria: 1. People with malignant tumors (including blood system tumors); 2. Those who only used Rosasosta during hospitalization and didn’t continue it in outpatient care after discharge during the observation period; 3. Those who died or stopped dialysis during the observation period; 4. Those who transferred to another hospital and had no lab records from this hospital for more than a month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference in phosphate binder selection (high-risk: sevelamer/calcium acetate vs. low-risk: lanthanum carbonate/none) between the suboptimal anemia control group and the anemia target-achievement gro;Difference in physician order dosing interval labeling rate between the suboptimal anemia control group and the anemia target-achievement group.; | — |
Secondary
| Measure | Time frame |
|---|---|
| Difference in cumulative hospitalization days between the suboptimal anemia control group and the anemia target-achievement group.;Difference in hemoglobin mean value between the suboptimal anemia control group and the anemia target-achievement group.;Difference in combined ESA use proportion between the suboptimal anemia control group and the anemia target-achievement group.;Difference in nursing record dosing interval education documentation rate between the suboptimal anemia control group and the anemia target-achievement group.; | — |
Countries
China
Contacts
Public ContactShu Huang
Mindong Hospital of Ningde City
Outcome results
None listed